2026 TeoTwawKi ... 2032 Darkest Interregnum Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : 2026 TeoTwawKi ... 2032 Darkest Interregnum

GLD 414.48

+0.7%

Jan 9 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: TobagoJack who wrote (141175)	5/3/2018 9:24:59 PM
From: Elroy Jetson	Read Replies (1) of 219195

State of the art in using stem cells universally as a therapy is no where close to the level communicated to you by a charlatan in Singapore. Simply flat-wrong claims based on no evidence. Rather than being elective procedures to keep healthy, most are wildly prospective with uncertain benefit and unknown and ill defined risk factors. The now blind woman in the article inexplicably agreed to treat both eyes simultaneously. No sensible ophthalmic surgeon would ever treat both eyes at the same time, but there is often cost pressure to do so if the routine surgery has a history of presenting few risks. Injecting an experimental harvest of stem cells into your eyes is wildly experimental rather routine or having well characterized risks, yet the stem cell purveyor took a chance and she went blind. Perhaps you'll be willing to be more sensible when this article is reprinted in the South China Daily, having at that point more acceptable Chinese characteristics which seems less frightening to you.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next